Decreased paraoxonase 1, arylesterase enzyme activity, and enhanced oxidative stress in patients with mitral and aortic valve insufficiency

Clinical Laboratory

Volumn 59, Issue 5-6, 2013, Pages 597-604

  Yilmaz, Necat ^a   Simsek, Nevin ^a   Aydin, Ozgur ^a   Yardan, Emirhan ^b   Aslan, Sakir ^c   Eren, Esin ^d   Yegin, Aysenur ^a   Buyukbas, Sadik ^e  

^a Central laboratories of Antalya Education and Research Hospital of Ministry of Health   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

^c Neurology clinic of Antalya Education and Research Hospital of Ministry of Health   (Turkey)

^d Nephrology Section   (Turkey)

^e MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Arylesterase; Heart valve disease; Oxidant; Oxidative stress; Paraoxonase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; AORTA VALVE REGURGITATION; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEART MUSCLE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MITRAL VALVE REGURGITATION; OXIDATIVE STRESS; VALVULAR HEART DISEASE;

AGED; ANTIOXIDANTS; AORTIC VALVE INSUFFICIENCY; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; OXIDATIVE STRESS; PROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC;

TOSCANA VIRUS;

EID: 84879399926     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120629     Document Type: Article

References (28)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11. (Pubitemid 44353666)
2. Fenoglio JJ Jr, Wagner BM. Studies in rheumatic fever. VI. Ultrastructure of chronic rheumatic heart disease. Am J Pathol 1973;73:623-40.
3. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999;19:1218-22. (Pubitemid 29227640)
4. Yilmaz N, Aydin O, Yegin A, Tiltak A, Eren E. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin. Biochem. 2011;44:832-837.
5. Yilmaz N. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Arch Med Sci 2012;8:138-53.
6. T Gaillard, S Parthasarathy, K Osei. HDL dysfunctionality (paraoxonase) is worse in nondiabetic, postmenopausal African American than in white women. Diabetes Care 2011;34:19.
7. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parma SL, La BN Du. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest 1998; 101:1581-90. (Pubitemid 28198486)
8. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalysing both activities. Drug Metab Dispos 1991;19:100-6.
9. Eckerson HW, Wyte CM, La Du BN. The human serum araoxonase/arylesterase polymorphism. Am J Hum Genet 1983;35:1126-38.
10. Haagen L, Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate. Eur J Clin Chem Clin Biochem 1992;30:391-5.
11. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
12. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation more stable ABTS radical cation. Clin Biochem 2004;37:277-85. (Pubitemid 38314881)
13. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003;133:563-6. (Pubitemid 37499328)
14. Eren E, Yilmaz N, Aydin O. High density lipoprotein and it's dysfunction. Open Biochem J 2012;6:78-93.
15. Cagirci G, Cay S, Karakurt O, et al. Paraoxonase activity might be predictive of the severity of aortic valve stenosis. J Heart Valve Dis 2010;19:453-8.
16. Ahmed MI, Gladden JD, Litovsky SH, et al. Increased Oxidative Stress and Cardiomyocyte Myofibrillar Degeneration in Patients with Chronic Isolated Mitral Regurgitation and Ejection Fraction > 60%. Am Coll Cardiol 2010;55: 671-9.
17. Chen MC, Chang JP, Liu WH, et al. Increased serum oxidative stress in patients with severe mitral regurgitation: A new finding and potential mechanism for atrial enlargement. Clin Biochem 2009;42:943-8.
18. Rabus M, Demirbag R, Sezen Y, et al. Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease. Arch Turk Soc Cardiol 2008;36:536-40.
19. Davutoglu V, Celik A, Aksoy M. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. J Heart Valve Dis 2005;14:251-6. (Pubitemid 47046907)
20. Filip DA, Nistor A, Bulla A, Radu A, Lupu F, Simionescu M. Cellular events in the development of valvular atherosclerotic lesions induced by experimental hypercholesterolemia. Atherosclerosis 1987;67:199-214. (Pubitemid 17132994)
21. Mehrabi MR, Sinzinger H, Ekmekcioglu C, et al. Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis. Cardiovasc Res 2000;45:874-82. (Pubitemid 30089649)
22. Phillippi JA, Klyachko EA, Kenny JP 4th, Eskay MA, Gorman RC, Gleason TG. Basal and Oxidative Stress-Induced Expression of Metallothionein is Decreased in Ascending Aortic Aneurysms of Bicuspid Aortic Valve Patients. Circulation 2009;119:2498-506.
23. Keaney JF Jr, Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 1995;95:2520-9.
24. Saha N, Roy AC, Teo SH, Tay JS, Ratnam SS. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 1991;40:277-82.
25. Chang JP, Chen MC, Liu WH, et al. Atrial myocardial nox2 containing NADPH oxidase activity contribution to oxidative stress in mitral regurgitation: potential mechanism for atrial remodeling. Cardiovasc Pathol 2011;20: 99106.
26. Corradi D, Callegari S, Maestri R, et al. Heme oxygenase-1 expression in the left atrial myocardium of patients with chronic atrial fibrillation related to mitral valve disease: its regional relationship with structural remodeling. Hum Pathol 2008;39:1162-71.
27. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Peña-Silva R, Heistad DD. Dysregulation of Antioxidant Mechanisms Contributes to Increased Oxidative Stress in Calcific Aortic Valvular Stenosis in Humans. J Am Coll Cardiol 2008;52:843-50.
28. Huey KA, Fiscus G, Richwine AF, Johnson RW, Meador BM. In vivo vitamin E administration attenuates interleukin-6 and interleukin-1β responses to an acute inflammatory insult in mouse skeletal and cardiac muscle. Exp Physiol 2008;93:1263.